Country Trust Bank’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-259
Closed -$4.8K 660
2026
Q1
$4.8K Hold
259
﹤0.01% 405
2025
Q4
$4.04K Hold
259
﹤0.01% 438
2025
Q3
$3.79K Buy
+259
New +$3.85K ﹤0.01% 458
2022
Q1
Sell
-367
Closed -$5K 485
2021
Q4
$5K Buy
+367
New +$5.15K ﹤0.01% 392

Other funds holding TAK

Country Trust Bank's TAK Position: Q2 2026 in Review

Country Trust Bank sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 259 shares — an estimated $4.8K sold.

Country Trust Bank first reported a position in TAK in Q4 2021 and held it in 4 quarters. The position peaked at $5K in Q4 2021. 112 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Country Trust Bank reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Country Trust Bank sold 259 Takeda Pharmaceutical shares in Q2 2026, an estimated $4.8K.
  • Country Trust Bank first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 4 quarters.
  • Country Trust Bank's Takeda Pharmaceutical position peaked at $5K in Q4 2021.
  • 112 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.